Terminated PHASE2 NCT01332916

Impact of Cancer on Memory Functioning: Understanding Disorders Using Approaches in Neuropsychology and Neuroimaging

Sponsor: Centre Francois Baclesse

Interventions cognitive tests and cerebral IRM

Updated 5 times since 2017 Last updated: Apr 24, 2014 Started: Dec 31, 2010 Primary completion: Dec 31, 2013 Completion: Apr 30, 2014

A PHASE2 clinical study on Breast Cancer and Healthy, this trial is terminated or withdrawn. The trial is conducted by Centre Francois Baclesse and has accumulated 5 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2

First recorded

Dec 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Francois Baclesse

Data source: Centre Francois Baclesse

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Caen, France